I’m a pharmacist and health economist, and I’ve spent the last 10 years working in Canada and internationally as a healthcare decision maker, consultant, and clinical lecturer at the University of Toronto.
I work one-on-one with drug formulary managers, clinical pharmacy managers, clinical pharmacists, and other decision-makers at PBM organizations. I’d like to take what I’ve learned and taught to walk you through 10 critical questions that will help you better evaluate new drugs. This will help your achieve the best possible health outcomes for your plan members and support drug plan sustainability at your organization.
